EGFR and non-small cell lung carcinoma: The largest numerical difference was noted in the 50–59 age group, yet with a p-value of 0.16, it did not attain significance, suggesting no strong evidence of sex predominance in EGFR-mutant NSCLC prevalence (Table 1).